Fujimura Y - Search Results

1

Safety and effectiveness of eculizumab for adult patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance.

Kato H, Miyakawa Y, Hidaka Y, Inoue N, Ito S, Kagami S, Kaname S, Matsumoto M, Mizuno M, Matsuda T, Shimono A, Maruyama S, Fujimura Y, Nangaku M, Okada H. Kato H, et al. Among authors: fujimura y. Clin Exp Nephrol. 2019 Jan;23(1):65-75. doi: 10.1007/s10157-018-1609-8. Epub 2018 Jun 29. Clin Exp Nephrol. 2019. PMID: 29959568 Free PMC article.

2

Von Willebrand factor-cleaving protease and Upshaw-Schulman syndrome.

Fujimura Y, Matsumoto M, Yagi H, Yoshioka A, Matsui T, Titani K. Fujimura Y, et al. Int J Hematol. 2002 Jan;75(1):25-34. doi: 10.1007/BF02981975. Int J Hematol. 2002. PMID: 11843286 Review.

3

Predicting response to plasma exchange in patients with thrombotic thrombocytopenic purpura with measurement of vWF-cleaving protease activity.

Mori Y, Wada H, Gabazza EC, Minami N, Nobori T, Shiku H, Yagi H, Ishizashi H, Matsumoto M, Fujimura Y. Mori Y, et al. Among authors: fujimura y. Transfusion. 2002 May;42(5):572-80. doi: 10.1046/j.1537-2995.2002.00100.x. Transfusion. 2002. PMID: 12084165

4

Successful treatment of a young infant who developed high-titer inhibitors against VWF-cleaving protease (ADAMTS-13): important discrimination from Upshaw-Schulman syndrome.

Ashida A, Nakamura H, Yoden A, Tamai H, Ishizashi H, Yagi H, Matsumoto M, Fujimura Y. Ashida A, et al. Among authors: fujimura y. Am J Hematol. 2002 Dec;71(4):318-22. doi: 10.1002/ajh.10228. Am J Hematol. 2002. PMID: 12447964 Free article.

5

[vWF-cleaving protease/ADAMTS 13].

Matsumoto M, Yagi H, Fujimura Y. Matsumoto M, et al. Among authors: fujimura y. Rinsho Ketsueki. 2003 Mar;44(3):159-67. Rinsho Ketsueki. 2003. PMID: 12722342 Review. Japanese. No abstract available.

6

VWF73, a region from D1596 to R1668 of von Willebrand factor, provides a minimal substrate for ADAMTS-13.

Kokame K, Matsumoto M, Fujimura Y, Miyata T. Kokame K, et al. Among authors: fujimura y. Blood. 2004 Jan 15;103(2):607-12. doi: 10.1182/blood-2003-08-2861. Epub 2003 Sep 25. Blood. 2004. PMID: 14512308 Free article.

7

Molecular characterization of ADAMTS13 gene mutations in Japanese patients with Upshaw-Schulman syndrome.

Matsumoto M, Kokame K, Soejima K, Miura M, Hayashi S, Fujii Y, Iwai A, Ito E, Tsuji Y, Takeda-Shitaka M, Iwadate M, Umeyama H, Yagi H, Ishizashi H, Banno F, Nakagaki T, Miyata T, Fujimura Y. Matsumoto M, et al. Among authors: fujimura y. Blood. 2004 Feb 15;103(4):1305-10. doi: 10.1182/blood-2003-06-1796. Epub 2003 Oct 16. Blood. 2004. PMID: 14563640 Free article.

8

Von Willebrand factor--cleaving protease activity in thrombotic microangiopathy after living donor liver transplantation: a case report.

Nakazawa Y, Hashikura Y, Urata K, Ikegami T, Terada M, Yagi H, Ishizashi H, Matsumoto M, Fujimura Y, Miyagawa S. Nakazawa Y, et al. Among authors: fujimura y. Liver Transpl. 2003 Dec;9(12):1328-33. doi: 10.1016/j.lts.2003.09.021. Liver Transpl. 2003. PMID: 14625834 Free article.

9

The Japanese experience with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.

Matsumoto M, Yagi H, Ishizashi H, Wada H, Fujimura Y. Matsumoto M, et al. Among authors: fujimura y. Semin Hematol. 2004 Jan;41(1):68-74. doi: 10.1053/j.seminhematol.2003.10.009. Semin Hematol. 2004. PMID: 14727261

10

[Changes of ADAMTS13 activity and endothelial cell markers in TMA cases].

Mori Y, Wada H, Shiku H, Yagi H, Matsumoto M, Fujimura Y. Mori Y, et al. Among authors: fujimura y. Rinsho Ketsueki. 2004 May;45(5):378-82. Rinsho Ketsueki. 2004. PMID: 15199746 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

947 results

Search Page

Filters